LOXL2 (lysyl oxidase like 2), an enzyme involved in collagen crosslinking, is known to promote tumor invasiveness and metastasis through extracellular matrix remodeling and has been linked to poor outcomes in various tumors, including lung cancer [50]. This evidence concerns the gene LOXL2 and lung cancer.